{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:00:49Z","timestamp":1790758849210,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.heliyon.2023.e20155","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T19:33:14Z","timestamp":1694892794000},"page":"e20155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-5278","authenticated-orcid":false,"given":"Mohammed I.","family":"Danjuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-9074","authenticated-orcid":false,"given":"Rana","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6912-0551","authenticated-orcid":false,"given":"Maryam","family":"Aboughalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6709-8506","authenticated-orcid":false,"given":"Aseel","family":"Hassona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basant Selim","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elshafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelnaser","family":"Elzouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.heliyon.2023.e20155_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e20155_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112193","article-title":"Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective","volume":"143","author":"Al-Kuraishy","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"27","key":"10.1016\/j.heliyon.2023.e20155_bib3","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e20155_bib4","article-title":"Prevention of covid-19 with the BNT162b2 and mRNA-1273 vaccines","volume":"385","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e20155_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2020.03.025","article-title":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","volume":"18","author":"Beck","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.heliyon.2023.e20155_bib6","first-page":"248","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e20155_bib7","first-page":"253","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 rna dependent rna polymerase (RdRp): a molecular docking study","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20155_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7816","key":"10.1016\/j.heliyon.2023.e20155_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e20155_bib10","volume":"vol. 72","author":"Singh","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e20155_bib11","volume":"vol. 80","author":"Reyes","year":"2021"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20155_bib12","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s10753-022-01648-7","article-title":"The prospective effect of allopurinol on the oxidative stress index and endothelial dysfunction in Covid-19","volume":"45","author":"Al-Kuraishy","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2023.e20155_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.749291","article-title":"Effects of \u03b2-blockers on the sympathetic and cytokines storms in covid-19","volume":"12","author":"Al-Kuraishy","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20155_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","volume":"9","author":"Tardif","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20155_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13645","article-title":"Colchicine use might be associated with lower mortality in COVID-19 patients: a meta-analysis","volume":"51","author":"Elshafei","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20155_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102395","article-title":"Effect of colchicine on mortality in patients with COVID-19 \u2013 a systematic review and meta-analysis","volume":"16","author":"Zein","year":"2022","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"issue":"12 December","key":"10.1016\/j.heliyon.2023.e20155_bib17","first-page":"16","article-title":"Colchicine use in patients with COVID-19: a systematic review and meta-analysis","author":"Chiu","year":"2021","journal-title":"PLoS One"},{"issue":"4 April","key":"10.1016\/j.heliyon.2023.e20155_bib18","first-page":"17","article-title":"Safety and efficacy of colchicine in COVID-19 patients: a systematic review and meta-analysis of randomized control trials","author":"Yasmin","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e20155_bib19","first-page":"9","article-title":"Efficacy of COVID-19 treatments: a bayesian network meta-analysis of randomized controlled trials","author":"Zhang","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.heliyon.2023.e20155_bib20","first-page":"35","article-title":"The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: meta-analysis","author":"Golpour","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20155_bib21","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1097\/MJT.0000000000001511","article-title":"The effect of colchicine on mortality, mechanical ventilation, and length of stay in patients with COVID-19 infection: an updated systematic review and meta-analysis of randomized clinical trials","volume":"29","author":"Romeo","year":"2022","journal-title":"Am. J. Therapeut."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20155_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.hjc.2020.11.012","article-title":"Impact of colchicine on mortality in patients with COVID-19: a meta-analysis","volume":"62","author":"Vrachatis","year":"2021","journal-title":"Hellenic J. Cardiol."},{"issue":"22","key":"10.1016\/j.heliyon.2023.e20155_bib23","first-page":"7151","article-title":"Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis","volume":"25","author":"de-miguel-balsa","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"41","key":"10.1016\/j.heliyon.2023.e20155_bib24","article-title":"Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: an updated network meta-analysis of 48 randomized controlled trials","volume":"101","author":"Cheng","year":"2022","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.heliyon.2023.e20155_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2023.02.009","article-title":"Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)","author":"Danjuma","year":"2023","journal-title":"Eur. J. Intern. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20155_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.heliyon.2023.e20155_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20155_bib38","first-page":"195","article-title":"L\u2019elogio dell\u2019incertezza: una revisione sistematica living per valutare l\u2019efficacia e la sicurezza dei trattamenti farmacologici per pazienti affetti da covid-19","volume":"112","author":"Cruciani","year":"2021","journal-title":"Recenti Prog. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20155_bib39","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/clc.23828","article-title":"Myocarditis after COVID\u201019 mRNA vaccination: a systematic review of case reports and case series","volume":"45","author":"Park","year":"2022","journal-title":"Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20155_bib40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/07853890.2021.1993327","article-title":"Impact of colchicine on mortality and morbidity in COVID-19: a systematic review","volume":"54","author":"Sanghavi","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.heliyon.2023.e20155_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.729559","article-title":"Efficacy of COVID-19 treatments: a Bayesian network meta-analysis of randomized controlled trials","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Public Health"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20155_bib42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7150\/thno.48342","article-title":"Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"issue":"162","key":"10.1016\/j.heliyon.2023.e20155_bib30","first-page":"30","article-title":"The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline","author":"Crichton","year":"2021","journal-title":"Eur. Respir. Rev."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e20155_bib31","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1080\/03007995.2022.2100654","article-title":"The evidence from clinical trials on colchicine and corticosteroids' effect on COVID-19: a systematic review and meta-analysis","volume":"38","author":"Bitar","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20155_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/life11080864","article-title":"Repurposing colchicine in treating patients with covid-19: a systematic review and meta-analysis","volume":"11","author":"Lien","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.heliyon.2023.e20155_bib33","first-page":"96","article-title":"Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: a systematic review, meta-analysis, and meta-regression","author":"Nawangsih","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.heliyon.2023.e20155_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.amjcard.2021.02.005","article-title":"Meta-analysis of the effect of colchicine on mortality and mechanical ventilation in COVID-19","volume":"145","author":"Salah","year":"2021","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20155_bib37","article-title":"Colchicine for the treatment of COVID\u201019","volume":"2021","author":"Group","year":"1996","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20155_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/iid3.562","article-title":"The effect of colchicine on mortality outcome and duration of hospital stays in patients with COVID-19: a meta-analysis of randomized trials","volume":"10","author":"Kow","year":"2022","journal-title":"Immun Inflamm Dis"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20155_bib43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20155_bib36","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3390\/jcm11092615","article-title":"Efficacy of colchicine in the treatment of COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Toro-Huamanchumo","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2023.e20155_bib44","article-title":"Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19","author":"Bhimraj","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e20155_bib45","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ (Online)."},{"key":"10.1016\/j.heliyon.2023.e20155_bib46","volume":"vol. 71","author":"Bonaventura","year":"2022"},{"issue":"19","key":"10.1016\/j.heliyon.2023.e20155_bib47","first-page":"382","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e20155_bib48","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e20155_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20155_bib29","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/07853890.2022.2096919","article-title":"Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials","volume":"54","author":"Lan","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.heliyon.2023.e20155_bib50","series-title":"Colchicine May Interfere with the Efficacy of the Adenoviral Vector\u2013Based Vaccine for COVID-19. Vol. 15, Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders","author":"Lin","year":"2022"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20155_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/1440-1681.13488","article-title":"Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"48","author":"Hariyanto","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.heliyon.2023.e20155_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejim.2022.10.016","article-title":"Treatment with COLchicine in hospitalized patients affected by COVID-19: the COLVID-19 trial","volume":"107","author":"Perricone","year":"2023","journal-title":"Eur. J. Intern. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023073632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023073632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:18:17Z","timestamp":1790756297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023073632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2405844023073632"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20155","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e20155"}}